Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

February 2015 Issue of The Medicine Maker

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Business Practice

Collaborate or Stagnate

| Charlotte Barker

Can pharma get over its IP anxiety and embrace meaningful partnerships?

Manufacture Bioprocessing - Upstream & Downstream

How Do You Like Your Eggs?

| Charlotte Barker

Scientists in California have ‘unboiled’ an egg – with some interesting implications for biopharma...

Business & Regulation Business Practice

Orphan Affordability

| Stephanie Sutton

Research into rare diseases is on the rise, but are prices sustainable?

Business & Regulation Standards & Regulation

Violation Without Intent?

| Stephanie Sutton

Research into rare diseases is on the rise, but are prices sustainable?

Business & Regulation Business Practice

Pfizer-Fuelled Rumors

| Charlotte Barker

Could the Pfizer–Hospira deal be a stepping stone to a company split?

Business & Regulation Standards & Regulation

Good Things Come in Small Packages

| Charlotte Barker

Is early and regular dialogue with regulatory agencies the key to success for smaller companies?

Business & Regulation Business Practice

Who Are the Most Powerful Medicine Makers?

| Charlotte Barker

Only you have the answer. Nominate now.

Manufacture Advanced Medicine

Better, Faster, CRISPR

| Stephanie Sutton

Pharma companies look to new genetic screening technology to enhance drug discovery.

Manufacture Small Molecules

Rise of the Machines

| Stephanie Sutton

A ‘robot scientist’, capable of independently carrying out drug screening research, has been developed by UK researchers.

Manufacture Advanced Medicine

A Personal Question

| Claire Thompson

Can nanotechnology pick up where personalized medicine leaves off?

Manufacture Small Molecules

Classifying Manufacture

| Michael Leane

A classification system could make the R&D–manufacturing interface much easier to navigate.

Discovery & Development Clinical Trials

Women on the Verge of a Clinical Breakthrough

Women’s health used to be considered solely in terms of maternal and reproductive health. Not anymore.

Manufacture Technology and Equipment

Who’s Developing Your Process?

| Jan Gunnar Gustafsson

Cutting corners in process development will come back to haunt you – especially in the biopharmaceutical arena.

Manufacture Business Practice

Meet The Green Team

| Andy Wells

Pushing for cleaner, greener manufacturing is not only good for the planet, it’s great for business.


Chemical Alliances

A multimillion Euro project is pushing green chemistry forward in Europe. The secret of its success? Collaboration, collaboration, collaboration!

Manufacture Small Molecules

How Green is Green?

The field of green chemistry is concerned with minimization of waste and avoidance of toxic and hazardous substances in pharmaceutical products.

Manufacture Small Molecules

Smarter Synthesis

| Leena Otsumaa

Green thinking sometimes seems a long way off for those of us in medicinal chemistry

Manufacture Bioprocessing - Upstream & Downstream

Greening Biopharma

At Genentech, a member of the Roche Group, the Green BioPharma program aims to bring sustainability into R&D labs.

Discovery & Development Ingredients

Sustainable Ingredients

| Daniele Piergentili

Climate change, health challenges, and resource inefficiencies or shortages are very high on the agenda of societies around the world. And rightly so

Manufacture Business Practice

A Fresh Pair of Eyes

| Stephanie Sutton

Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.

Discovery & Development Formulation

Dare to Be Different

| Charlotte Miller

With regulators looking for more differentiation between tablets, we must be bolder with solid dosage designs.

Manufacture Ingredients

Model Manufacturing

Our ‘dynamic flowsheet model’ links API purification and processing with downstream tablet manufacturing to provide better control of the process variables

Manufacture Drug Delivery

Nanotechnology Versus Cancer

| Ronak Savla

With only one approved drug and many failures, the cancer vaccine field has lost some of its shine.

Manufacture Business Practice

Smooth Operator

Sitting Down With… James Christie, Project Director for Manufacturing, Association of the British Pharmaceutical Industry (ABPI), London, UK.

Other issues of 2015